Biological Characterization and Therapeutics for Subscalp Recurrent in Intracranial Glioblastoma

PURPOSE: Gliomas are common intracranial tumors, of which 70% are malignant gliomas. Glioblastoma multiforme (GBM) is the most aggressive tumor, and patients with GBM have a median survival time of only 9–12 months; extracranial recurrence of GBM is very rare. A therapeutic strategy for this kind of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Junwen, Fang, Sheng, Song, Wenjie, Zhang, Bo, Fan, Wenhua, Jin, Guishan, Liu, Fusheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498653/
https://www.ncbi.nlm.nih.gov/pubmed/32982297
http://dx.doi.org/10.2147/OTT.S265322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498653/
https://www.ncbi.nlm.nih.gov/pubmed/32982297
http://dx.doi.org/10.2147/OTT.S265322

Ejemplares similares